ArticleJournal of the American Board of Family Medicine : JABFM2026
Effect of Initiating HPV Vaccination Before Age 11 on HPV Vaccination Completion.
Article in Journal of the American Board of Family Medicine : JABFM, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- HPV Vaccination Predictors Among College Students.Journal of community health · 2026Article
- Point-of-Care Ultrasound, Prevention and Screening, Family Medicine Workforce, Navigating Systems, and Improving Patient Care.Journal of the American Board of Family Medicine : JABFMArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveThe human papillomavirus (HPV) vaccine, launched in 2006, has proven effective at reducing HPV infection rates and preventing HPV-associated cancers. However, less than 60% of adolescents have completed the recommended vaccine series, and the rate is even lower among Hispanic children and adolescents. This study explores the age of initiation within our comprehensive vaccination program in West Texas
methodsThis study is a retrospective analysis of HPV vaccine completion among individuals 9 to 17 years old from
resultsA total of 2,380 individuals were enrolled, and this study analyzed a subset of 613 children aged 9 to 17 years; 59.8% completed the vaccine series. Most were female (53.8%) and had parents born in Mexico (75.2%). Children 11 to 14 years old were likelier to complete the vaccine series than other age groups (OR: 2.802,
conclusionOur study supports advocating for initiating the HPV vaccine at a younger age and completing the series by 14 years old. Multi-component and culturally tailored programs are an effective means to increasing HPV vaccine uptake and decreasing the burden of HPV-associated cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.